All companies
ASKA Pharmaceutical Holdings Co Ltd logo

What smart money is saying about ASKA Pharmaceutical Holdings Co LtdJapan flag

4886.T · Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $370M

1 fund in our archive has pitched ASKA Pharmaceutical Holdings Co Ltd — most recently NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc in December 2025.

Company profile

ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.

1
Reported positions
0
Bought
0
Sold
1
Letter

Position history

Every position in ASKA Pharmaceutical Holdings Co Ltd on record in the archive was reported in Q4 2025, across 1 fund letter, with no move described.

Fund letters reporting a position in ASKA Pharmaceutical Holdings Co Ltd, by quarter
QuarterLettersBoughtSoldTheses
Q4 20251001

Fund activity · 1 position

  • HoldsNAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc
    December 2025

    Listed in NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc’s reported holdings.

    Read the letterASKA Pharmaceutical Holdings Co Ltd

Fund coverage · 1 thesis

  • NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc
    December 2025

    ASKA Pharmaceutical Holdings is supported by stronger growth, higher margins and ROE targets, and a strategy focused on women’s health, overseas expansion, and pipeline monetization.

    Read the full thesis

Read every full thesis on ASKA Pharmaceutical Holdings Co Ltd

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger